Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-FR Version v4-EN
Language French English
Date Updated 2020-11-13 2020-10-09
Drug Identification Number 02385465 02385465
Brand name AMIODARONE AMIODARONE
Common or Proper name AMIODARONE AMIODARONE
Company Name SIVEM PHARMACEUTICALS ULC SIVEM PHARMACEUTICALS ULC
Ingredients AMIODARONE HYDROCHLORIDE AMIODARONE HYDROCHLORIDE
Strength(s) 200MG 200MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100 100
ATC code C01BD C01BD
ATC description ANTIARRHYTHMICS, CLASS I AND III ANTIARRHYTHMICS, CLASS I AND III
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2020-08-24 2020-08-24
Actual start date 2020-09-08 2020-09-08
Estimated end date 2020-11-30 2020-10-30
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments